{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52.0"},{"groupId":"OG001","value":"41.7"}]}],"title":"Mobility: No Problems Walking"},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.0"},{"groupId":"OG001","value":"25.0"}]}],"title":"Mobility: Slight Problems Walking"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.0"},{"groupId":"OG001","value":"33.3"}]}],"title":"Mobility: Moderate Problems Walking"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0"},{"groupId":"OG001","value":"0.0"}]}],"title":"Mobility: Severe Problems Walking"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"0.0"}]}],"title":"Mobility: Unable to Walk"},{"categories":[{"measurements":[{"groupId":"OG000","value":"88.0"},{"groupId":"OG001","value":"83.3"}]}],"title":"Self-Care: No Problems Washing or Dressing"},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0"},{"groupId":"OG001","value":"16.7"}]}],"title":"Self-Care: Slight Problems Washing or Dressing"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0"},{"groupId":"OG001","value":"0.0"}]}],"title":"Self-Care: Moderate Problems Washing or Dressing"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0"},{"groupId":"OG001","value":"0.0"}]}],"title":"Self-Care: Severe Problems Washing or Dressing"},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.0"},{"groupId":"OG001","value":"33.3"}]}],"title":"Usual Activities: No Problems Doing Usual Activities"},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.0"},{"groupId":"OG001","value":"41.7"}]}],"title":"Usual Activities: Slight Problems Doing Usual Activities"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.0"},{"groupId":"OG001","value":"25.0"}]}],"title":"Usual Activities: Moderate Problems Doing Usual Activities"},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0"},{"groupId":"OG001","value":"0.0"}]}],"title":"Usual Activities: Severe Problems Doing Usual Activities"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"0.0"}]}],"title":"Usual Activities: Unable to do Usual Activities"},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.0"},{"groupId":"OG001","value":"41.7"}]}],"title":"Pain/Discomfort: No Pain or Discomfort"},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.0"},{"groupId":"OG001","value":"33.3"}]}],"title":"Pain/Discomfort: Slight Pain or Discomfort"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.0"},{"groupId":"OG001","value":"25.0"}]}],"title":"Pain/Discomfort: Moderate Pain or Discomfort"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0"},{"groupId":"OG001","value":"0.0"}]}],"title":"Pain/Discomfort: Severe Pain or Discomfort"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0"},{"groupId":"OG001","value":"0.0"}]}],"title":"Pain/Discomfort: Extreme Pain or Discomfort"},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.0"},{"groupId":"OG001","value":"33.3"}]}],"title":"Anxiety/Depression: Not Anxious or Depressed"},{"categories":[{"measurements":[{"groupId":"OG000","value":"44.0"},{"groupId":"OG001","value":"33.3"}]}],"title":"Anxiety/Depression: Slightly Anxious or Depressed"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0"},{"groupId":"OG001","value":"25.0"}]}],"title":"Anxiety/Depression: Moderately Anxious or Depressed"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0"},{"groupId":"OG001","value":"8.3"}]}],"title":"Anxiety/Depression: Severely Anxious or Depressed"}],"denoms":[{"counts":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"description":"The EQ-5D-5L assesses general health-related quality of life. Health is defined in 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Percentages are rounded off to whole number at the nearest decimal.","groups":[{"description":"Participants received AG-120 500 mg, tablet, orally, QD in each 28-day treatment cycle, until occurrence of disease progression, unacceptable toxicity, confirmed pregnancy, death, subject withdrawal, lost to follow-up, or the sponsor ended the study for up to approximately 45 months.","id":"OG000","title":"AG-120"},{"description":"Participants received AG-120 matched placebo, orally, QD in each 28-day treatment cycle, until occurrence of disease progression, unacceptable toxicity, confirmed pregnancy, death, subject withdrawal, lost to follow-up or the sponsor ended the study for up to approximately 7 months. Participants who experienced disease progression and received placebo were allowed to cross over and receive AG-120.","id":"OG001","title":"Placebo"}],"paramType":"NUMBER","populationDescription":"ITT population included all participants who were randomized, with the treatment group designated according to the randomization. Overall number analyzed is the number of participants available for analysis.","reportingStatus":"POSTED","timeFrame":"Cycle 3 Day 1","title":"Percentage of Participants With Each EuroQol 5 Dimensions 5 Levels (EQ-5D-5L) Dimension Response","type":"SECONDARY","unitOfMeasure":"percentage of participants"}